DBD vs WELL · P/E 28, rev $3.75B vs P/E 100, rev $10.84B
Diebold Nixdorf, Incorporated (DBD) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Diebold Nixdorf, Incorporated (DBD) is a software - application company listed on US.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported DBD revenue for 2024-12-31 was $3.75B. Net income was -$14.5M. Revenue was up 130.3% from 2023-12-31 to 2024-12-31. DBD currently screens at market cap $2.82B and trailing P/E 28.1.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
DBD currently screens at market cap $2.82B and trailing P/E 28.1. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the DBD and WELL stock pages for the full models.
Not investment advice.